Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Otsuka Holdings Co., Ltd.    4578   JP3188220002

OTSUKA HOLDINGS CO., LTD.

(4578)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
4420 4457 4468 4464 4413 Last
486600 544500 606300 814800 567900 Volume
+0.14% +0.84% +0.25% -0.09% -1.14% Change
Financials
Sales 2020 1 426 B 13 756 M 13 756 M
Net income 2020 154 B 1 484 M 1 484 M
Net cash position 2020 223 B 2 147 M 2 147 M
P/E ratio 2020 15,8x
Yield 2020 2,24%
Sales 2021 1 434 B 13 835 M 13 835 M
Net income 2021 149 B 1 433 M 1 433 M
Net cash position 2021 304 B 2 932 M 2 932 M
P/E ratio 2021 16,2x
Yield 2021 2,27%
Capitalization 2 421 B 23 382 M 23 358 M
EV / Sales 2020 1,54x
EV / Sales 2021 1,48x
Nbr of Employees 32 992
Free-Float 74,7%
More Financials
Company
Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity: - manufacture and sale of pharmaceutical products (64.4% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices; - manufacture and sale... 
Sector
Pharmaceuticals
Calendar
02/12Earnings Release
More about the company
Notations Surperformance© of Otsuka Holdings Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about OTSUKA HOLDINGS CO., LTD.
01/15OTSUKA : Taiho Pharmaceutical Announces Establishment of a New Company as a Clin..
AQ
01/12PRESS RELEASE : Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0..
DJ
2020OTSUKA HOLDINGS CO., LTD. : Ex-dividend day for final dividend
FA
2020OTSUKA : Health Comic Library Celebrates 30 Years
AQ
2020Dual-Listed Aurinia In Collaboration and Licensing Agreement with Otsuka Phar..
MT
2020Aurinia Pharmaceuticals to Collaborate With Otsuka Pharmaceutical for Develop..
MT
2020OTSUKA : Health Comic Library Celebrates 30 Years Revamped website aims to furth..
PU
2020OTSUKA : Reports Results of Two Global Clinical Trials for Uncontrolled Hyperten..
MT
2020OTSUKA : Announces Results of Two International Clinical Studies in Patients wit..
PU
2020OTSUKA : announces 3Q FY2020 financial results
PU
2020OTSUKA HOLDINGS CO., LTD. : 3rd quarter results
CO
2020OTSUKA HOLDINGS CO., LTD. : quaterly earnings release
2020OTSUKA : ABILIFY MAINTENA approved for the additional indication of bipolar I di..
PU
2020Japan looks to AI as coronavirus challenges go-and-see quality control mantra
RE
2020OTSUKA HOLDINGS CO., LTD. : Press Release
CO
More news
News in other languages on OTSUKA HOLDINGS CO., LTD.
2020BOURSES ASIATIQUES : Tokyo rassurée, Hong Kong préoccupée
2020Tokyo clôture en hausse, le moral des entreprises japonaises s'améliore
2020OTSUKA HOLDINGS CO., LTD. : Veröffentlichung des Quartalsergebnisses
2020OTSUKA HOLDINGS CO., LTD. : publication des résultats trimestriels
2020Tokyo finit en retrait, plombée par SoftBank Group
More news
Chart OTSUKA HOLDINGS CO., LTD.
Duration : Period :
Otsuka Holdings Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OTSUKA HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 4 665,00 JPY
Last Close Price 4 464,00 JPY
Spread / Highest target 21,0%
Spread / Average Target 4,50%
Spread / Lowest Target -3,67%
EPS Revisions
Managers and Directors
NameTitle
Tatsuo Higuchi President, CEO & Representative Director
Ichiro Otsuka Chairman
Yuko Makino Chief Financial Officer & Director
Sadanobu Tobe Director
Noriko Tojo Director